3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sexual Dysfunctions, Psychological
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms, Second Primary
1
Metabolic Syndrome
1
Inflammation
1
Hematopoietic and Lymphatic System Neoplasm
1
Healthy Adult Participants
1
Dyslipidemias
1
Carcinoma, Non-Small-Cell Lung
1
Behavior, Addictive
1
Interventions
Varenicline
1
Tyrosine Kinase Inhibitors
1
Trastuzumab
1
Tobacco Use Cessation Devices
1
Registries
1
Patient Reported Outcome Measures
1
Nicotine Chewing Gum
1
Interviews as Topic
1
Cisplatin
1
Bupropion
1
Bleomycin
1
Anthracyclines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Second Primary
×
Bupropion
×
1 year
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled